Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Larson, Richard A.
One or more keywords matched the following items that are connected to
Larson, Richard A.
Item Type
Name
Concept
Core Binding Factors
Concept
Core Binding Factor Alpha 2 Subunit
Academic Article
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy.
Academic Article
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Academic Article
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
Academic Article
Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.
Academic Article
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
Academic Article
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission.
Academic Article
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Academic Article
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
Academic Article
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Academic Article
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Academic Article
Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801.
Search Criteria
Core Binding Factors